$FUSZ: ENGAGING THE INVESTMENT WORLD~~EXPECT MAJOR

New Post Public Reply Private Reply Replies (0) Message Board
SHEEPWOLF
808
$FUSZ: ENGAGING THE INVESTMENT WORLD~~EXPECT MAJOR ANNOUNCEMENTS
MONDAY 04/09/18 CEO RORY CUTAIA WILL BE SPEAKING ABOUT OUR COMPANY AND DEMONSTRATING OUR GAME CHANGING TECHNOLOGY LIVE AT 3:00pm EST
1407372600_Essexhouse.jpg


126213043_majorannouncement.gif
989955842_SuiteWorld.png
1074071522_page02logos.png
126213043_majorannouncement.gif
788556798_ScreenshotofTheMarketingNationSummit,April29-May2,2018%E2%80%93Marketo-Home.jpg
197098621_bigpage002.png
2115793437_cleanbalancesheetbanner.png
1852923_EPIC.png
Sojourner here following God, obeying God, and cleaving to Him. The journey is onward.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Super Hi Reports Strong Q2 2024 Financial Results

Updated Category News Views 223

Super Hi Reports Impressive Q2 2024 Financial Results Super Hi International Holding Ltd. (NASDAQ: HDL and HKEX: 9658), a prominent brand in Chinese cuisine known for its Haidilao hot pot restaurants worldwide, has announced its unaudited financial results for the second quarter of FY2024, which ended on June 30, 2024. Financial Highlights for Q2 2024 The company's...

Continue Reading
BEN Expands AI Reach with $1M Accelevate Stake

Updated Category News Views 4

A Strategic Move with a Million-Dollar Stake What do you call a million bucks invested in a company called Accelevate? Well, Brand Engagement Network, Inc. (NASDAQ: BNAI) seems to think it's just good business sense. They've tossed a cool million at Accelevate Solutions, snagging themselves about 10% ownership straight off the bat. Let me tell you, when folks throw around...

Continue Reading
Vasa Therapeutics Accelerates Heart Failure Treatment with VS-041

Updated Category News Views 266

Vasa Therapeutics Receives FDA Fast Track Designation for VS-041 Vasa Therapeutics, a biopharmaceutical company focused on innovative therapies for cardiovascular issues, is making significant strides with its lead investigational drug, VS-041. Recently, the FDA granted Fast Track designation for this unique treatment aimed at addressing heart failure with preserved...

Continue Reading
Legal Action Launched for Acadia Healthcare Investors Amid Concerns

Updated Category News Views 52

Introduction to the Class Action Lawsuit The Law Offices of Frank R. Cruz has initiated a class action lawsuit on behalf of investors of Acadia Healthcare Company Inc. (NASDAQ: ACHC). This legal motion concerns individuals and entities who purchased or acquired Acadia securities during a specified period. The lawsuit is rooted in serious allegations regarding the...

Continue Reading
Linux Foundation Launches Akrites for Open Source Security

Updated Category News Views 18

The Battle Against AI-Driven Vulnerabilities Alright, let's dive into this. These days, open source software is the backbone holding up pretty much every industry out there. Banking, healthcare, energy—you name it, it's running on it. But here's the kicker: AI's making it a heck of a lot easier for the bad guys to find holes in it. The Linux Foundation just christened...

Continue Reading